Skip to content
Creating Pharmaceuticals to Improve Neurological Function episode artwork

Aug 31, 2021 25 min

Creating Pharmaceuticals to Improve Neurological Function

from Meat & Potatoes Podcast Hosted by Silicon Slopes

Rob Etherington is the President and CEO of Clene – a clinical stage biopharmaceutical company. Clene's goal is to create the first drug asset to improve neurological function and strives to create assets to help those with ALS, multiple sclerosis, and Parkinson's Disease. Clene will know by the end of 2021 if their new asset can be used to treat all three of these diseases. Listen to learn more about this company and Rob's various roles as the CEO of a biopharmaceutical company.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Creating Pharmaceuticals to Improve Neurological Function

0:00 25:00

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Meat & Potatoes Podcast?

This episode is 25 minutes long.

When was this Meat & Potatoes Podcast episode published?

This episode was published on August 31, 2021.

Can I download this Meat & Potatoes Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.